HMGB-1 antagonists (Cornerstone Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHMGB-1 antagonists (Cornerstone Therapeutics)
Drug Alias NameHMGB-1 antagonists (MedImmune/Cornerstone Therapeutics)HMGB-1 antagonists (MedImmune/Critical Therapeutics)MGB-1 antagonists (Critical Therapeutics/MedImmune)high mobility group box chromosomal protein 1 antagonists (MedImmune/Cornerstone Therapeutics)anti-HMGB-1 MAb +[8] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsInflammationArthritis, RheumatoidSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCritical Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Usa IncMedimmune LlcCritical Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, RheumatoidSepsis

Other Information

ATC CodeN/A
Related LinksN/A